Cargando…

A novel biomarker panel for irritable bowel syndrome and the application in the general population

Biological markers that measure gut health and diagnose functional gastro-intestinal (GI) disorders, such as irritable bowel syndrome (IBS), are lacking. The objective was to identify and validate a biomarker panel associated with the pathophysiology of IBS that discriminates IBS from healthy contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mujagic, Zlatan, Tigchelaar, Ettje F., Zhernakova, Alexandra, Ludwig, Thomas, Ramiro-Garcia, Javier, Baranska, Agnieszka, Swertz, Morris A., Masclee, Ad A. M., Wijmenga, Cisca, van Schooten, Frederik J., Smolinska, Agnieszka, Jonkers, Daisy M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893613/ https://www.ncbi.nlm.nih.gov/pubmed/27263852 http://dx.doi.org/10.1038/srep26420

Ejemplares similares

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics
por: Tigchelaar, Ettje F, et al.
Publicado: (2015)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
por: Vich Vila, Arnau, et al.
Publicado: (2020)

Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening
por: Cheng, Hao Ran, et al.
Publicado: (2022)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis
por: Pijls, Kirsten E., et al.
Publicado: (2016)

The fecal microbiota as a biomarker for disease activity in Crohn’s disease
por: Tedjo, Danyta. I., et al.
Publicado: (2016)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

The influence of a short-term gluten-free diet on the human gut microbiome
por: Bonder, Marc Jan, et al.
Publicado: (2016)

Sugar Beet Pectin Supplementation Did Not Alter Profiles of Fecal Microbiota and Exhaled Breath in Healthy Young Adults and Healthy Elderly
por: An, Ran, et al.
Publicado: (2019)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency
por: Jankipersadsing, Soesma A, et al.
Publicado: (2017)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

Habitual dietary intake of IBD patients differs from population controls: a case–control study
por: Peters, Vera, et al.
Publicado: (2020)

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

Context-specific effects of genetic variants associated with autoimmune disease
por: Jonkers, Iris H., et al.
Publicado: (2017)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

The MHC locus and genetic susceptibility to autoimmune and infectious diseases
por: Matzaraki, Vasiliki, et al.
Publicado: (2017)

Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes
por: Conchillo, José M., et al.
Publicado: (2021)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Lifelines NEXT: a prospective birth cohort adding the next generation to the three-generation Lifelines cohort study
por: Warmink-Perdijk, Willemijn D. B., et al.
Publicado: (2020)

The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
por: Fu, Jingyuan, et al.
Publicado: (2015)

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

The Involvement of Intestinal Tryptophan Metabolism in Inflammatory Bowel Disease Identified by a Meta-Analysis of the Transcriptome and a Systematic Review of the Metabolome
por: Wang, Shan, et al.
Publicado: (2023)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012)

Studying the gut virome in the metagenomic era: challenges and perspectives
por: Garmaeva, Sanzhima, et al.
Publicado: (2019)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes
por: Lopera Maya, Esteban A., et al.
Publicado: (2020)

The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
por: Vork, Lisa, et al.
Publicado: (2018)

Liver Impairment—The Potential Application of Volatile Organic Compounds in Hepatology
por: Stavropoulos, Georgios, et al.
Publicado: (2021)

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
por: Wills, Edgar S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2rnden3fa358lfspaq1hvn6b82